Pharmacokinetic features: absorption, distribution, and elimination
The path of erythromycin in the patient's body has a number of critically important features that directly affect the rules of its administration. When taken orally, the absorption of the active substance is quite slow. The molecule of this natural macrolide is extremely unstable in an acidic environment: it undergoes partial destruction under the aggressive action of gastric juice. The final bioavailability of the drug is negatively affected by two main factors — the presence of food in the gastrointestinal tract and the high acidity of the environment.
After successful absorption into the systemic circulation, the drug begins to distribute into body tissues, doing so extremely unevenly. It penetrates excellently into bronchial secretions and bile. In these biological fluids, the antibiotic is able to accumulate, creating high, therapeutically significant concentrations necessary to suppress infection. At the same time, the drug has poor penetration across the blood-brain barrier (BBB), so its concentration in the tissues of the central nervous system remains minimal.
The process of elimination (excretion) occurs predominantly via the hepatobiliary system — the antibiotic leaves the body along with bile. The duration of the therapeutic effect of the drug is very short, ranging from only 4 to 6 hours, which dictates the need for multiple doses throughout the day.
Safety profile: effects on the gastrointestinal tract
The safety profile of erythromycin has a clear specificity: the vast majority of adverse reactions affect the gastrointestinal tract and hepatobiliary system. Moreover, gastrointestinal disorders are recorded most frequently in clinical practice.
At the heart of these side effects lies an interesting pharmacological mechanism. The drug possesses its own pronounced prokinetic activity. This means that it is capable of directly stimulating gastrointestinal motility, causing it to contract more actively than usual.
Clinically, this hyperstimulation manifests as a spectrum of dyspeptic symptoms. Patients regularly complain of nausea, episodes of vomiting, diarrhea, and a complete lack of appetite during therapy. To correct this condition and ease the patient's well-being, a simple pharmacological approach is used: the drug is prescribed strictly after meals. Despite the fact that food somewhat reduces the overall bioavailability of the medication, this method of administration significantly reduces the severity of unpleasant digestive symptoms.
Hepatotoxicity and dangerous drug interactions
The second major target for macrolide side effects is the liver. The use of this antibiotic is associated with a certain risk of hepatotoxicity. The most formidable clinical manifestation in this area is acute cholestatic hepatitis. This pathology is accompanied by a classic set of symptoms:
- the patient develops a fever;
- visible jaundice appears;
- laboratory tests show marked impairment of liver function.
Modern pharmacology suggests that the likely cause of such severe damage is a specific hypersensitivity reaction of the body to the administration of the drug.
Drug interactions of erythromycin deserve special and close attention from physicians. During biotransformation in the body, metabolites are formed that act as inhibitors of cytochrome P450 system isoenzymes located in the liver.
The clinical significance of this biochemical fact is enormous. If a patient is taking other medications in parallel that are normally metabolized by these same enzymatic pathways, their breakdown slows down sharply. This inevitably leads to an uncontrolled increase in the concentration of concomitant drugs in blood plasma. As a consequence, there is an extremely high risk of severe overdose from the medications the patient is taking alongside this antibiotic.
Briefly: answers to topical questions
What is the mechanism of the antibacterial action of erythromycin at the cellular level?
The mechanism of action of erythromycin consists of inhibiting protein synthesis at the ribosomal level. The drug binds to the 50S subunit of the bacterial ribosome, leading to the following effects:
- Blockade of the peptidyl transferase enzyme and disruption of peptide formation.
- Prevention of peptidyl-tRNA translocation.
As a result, peptide chain elongation is aborted. The type of drug action is bacteriostatic, since after the antibiotic is removed, the protein synthesis process resumes.
Which groups of bacteria are included in the antimicrobial spectrum of erythromycin?
The antimicrobial spectrum of erythromycin includes pathogens of typical and atypical infections. Susceptible microorganisms include:
- Pneumococci (as likely causative agents of primary lobar pneumonia).
- Atypical intracellular pathogens, including mycoplasmas, chlamydia, and legionella.
- Pathogens of specific gastrointestinal infections (indicated for campylobacteriosis and cholera).
The drug is used selectively when the pathogen is identified or empirically as an alternative agent.
Specifically which cytochrome P450 isoenzymes does erythromycin inhibit?
Erythromycin acts as an inhibitor of several specific cytochrome P450 isoenzymes in the liver. These include:
- CYP3A4 and CYP3A5 — the largest group of enzymes, metabolizing the majority of drugs.
- CYP1A2 — an isoenzyme whose activity depends on environmental factors and diet.
The suppression of these enzymes slows down the metabolism of other drugs, which is of great clinical significance due to the risk of drug interactions.
The concentration of which specific medications does erythromycin dangerously increase when taken concurrently?
When used concurrently, erythromycin dangerously increases the plasma concentration of the following groups of drugs:
- Antihistamines — their metabolism is slowed down due to inhibition of the CYP3A4 isoenzyme.
- Glucocorticoids — their concentration in the blood increases, creating a risk of overdose and enhanced side effects.
This is due to the fact that erythromycin metabolites inhibit hepatic cytochrome P450 isoenzymes, increasing the concentration of drugs metabolized by these same enzymes.
To easily remember the side effects of erythromycin, use the three "G" rule: Gastric tract (acts as a prokinetic, causing nausea), Gall (eliminated via bile, provokes cholestatic hepatitis), Gital cytochrome P450 (inhibits its enzymes).
Class and exam questions
Why does erythromycin frequently cause diarrhea and abdominal pain?
This antibiotic possesses its own prokinetic activity. It directly stimulates gastrointestinal motility, which leads to the development of nausea, vomiting, and diarrhea.
How does food intake affect the efficacy of erythromycin?
Food, like the acidic environment of the stomach, reduces the bioavailability of the drug. However, to reduce the severity of gastrointestinal side effects, it is still recommended to take it after meals.
Can erythromycin be used to treat CNS infections?
No, the drug crosses the blood-brain barrier (BBB) extremely poorly and is unable to create therapeutically significant concentrations in the cerebrospinal fluid.
What is the main danger of combining erythromycin with other drugs?
Its metabolites inhibit hepatic cytochrome P450 isoenzymes. This slows down the metabolism of concomitant drugs, increases their plasma concentration, and creates a high risk of overdose.
What else to study on this topic
- Mechanisms of natural macrolide destruction in the acidic environment of the stomach
- Receptor mechanisms of macrolide prokinetic activity
- Pathogenesis of macrolide-induced cholestatic hepatitis
- Clinically significant interactions of cytochrome P450 system inhibitors
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Erythromycin" and 5,304 other pages on the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antibacterial Chemotherapeutic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.